Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
100 hedge funds and large institutions have $486M invested in Lumos Pharma, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 15 closing their positions.
64% more capital invested
Capital invested by funds: $296M → $486M (+$190M)
60% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 15
27% more call options, than puts
Call options by funds: $59.5M | Put options by funds: $47M
9% more funds holding
Funds holding: 92 → 100 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$5.24M |
| 2 |
First Eagle Investment Management
New York
|
+$4.92M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.56M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.51M |
| 5 |
Barclays
London,
United Kingdom
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.9M |
| 2 |
PC
PointState Capital
New York
|
-$20.6M |
| 3 |
HT
HAP Trading
New York
|
-$6.16M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$4.1M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$3.91M |
LUMO Hedge Fund Activity: Q4 2014 in Review
100 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2014, worth a combined $486M — up 64% from $296M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new LUMO positions and 15 closed out — a net gain of 9 holders — while 27 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $5.24M. The largest seller was Fidelity Investments, cutting an estimated $37.9M.
- 100 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2014, up from 92 in Q3 2014.
- Funds reported $486M of Lumos Pharma, Inc. Common Stock stock for Q4 2014, up 64% quarter-over-quarter.
- 24 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2014 and 15 closed out, a net change of +9 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2014 was BlackRock Institutional Trust, an estimated $5.24M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q4 2014 was Fidelity Investments, an estimated $37.9M sold.
Based on aggregated 13F filings for Q4 2014.